US FDA warns Cadila Pharma over quality control standards in drug production
Cadila Pharmaceuticals is the latest home-grown drugmaker to face US regulatory rebuke, as the FDA intensifies its scrutiny of the generic drug firms.
Mumbai Last Updated: November 12, 2014 | 13:07 IST
Photo for representation purposes only. (Source: Reuters)